{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:50:20Z","timestamp":1789609820339,"version":"build-2803163510"},"reference-count":36,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2026,6,1]]},"abstract":"<jats:sec id=\"ab-hoi260021-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Sex-related disparities affect diagnosis, referral, and prognosis of aortic valvular diseases. Contemporary US data on transcatheter aortic valve implantation (TAVI) by sex are limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-hoi260021-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To characterize 10-year trends in TAVI use, periprocedural complications, and long-term outcomes among Medicare beneficiaries, stratified by sex.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-hoi260021-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This nationwide, retrospective, population-based cohort study used US Medicare claims data from fee-for-service beneficiaries discharged after TAVI from January 1, 2013, to December 31, 2022. The median follow-up time was 2.19 (IQR, 0.94-3.79) years. Exclusions included patients who had concomitant valve surgery, infective endocarditis, valve-in-valve TAVI, transapical TAVI, TAVI for pure aortic insufficiency, or later conversion to Medicare Advantage. Analyses were conducted between October 1, 2024, and April 1, 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-hoi260021-7\">\n                    <jats:title>Exposure<\/jats:title>\n                    <jats:p>TAVI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-hoi260021-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary outcome was all-cause mortality. Secondary outcomes included periprocedural mortality, vascular complications, acute kidney injury, major or life-threatening bleeding, stroke, acute myocardial infarction (AMI), permanent pacemaker implantation (PPI), and hospitalization for heart failure (HF). Adjusted odds ratios (AORs) and hazard ratios (AHRs) with 95% CIs were estimated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-hoi260021-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The study included 314\u202f123 patients (141\u202f233 women [45.0%] and 172\u202f890 men [55.0%]). Women were older than men (mean [SD] age, female: 80.3 [7.8] years; male: 79.4 [7.7] years; standardized mean difference, 12%). The proportion of female patients who underwent TAVI declined from 47.6% in 2013 to 43.6% in 2022 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001). Compared with men, women had higher periprocedural mortality (2.5% vs 2.2%; AOR, 1.20 [95% CI, 1.14-1.26]), vascular complications (5.8% vs 3.6%; AOR, 1.65 [95% CI, 1.60-1.71]), and bleeding (10.4% vs 6.8%; AOR, 1.67 [95% CI, 1.62-1.71]) but less PPI (16.9% vs 20.0%; AOR, 0.81 [95% CI, 0.79-0.82]). Long-term mortality was lower in female patients (AHR, 0.92; 95% CI, 0.91-0.93), although their risks of HF hospitalization, AMI, stroke, and bleeding were higher.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-hoi260021-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>Among Medicare beneficiaries, women constituted a progressively declining proportion of patients treated with TAVI, experienced more periprocedural complications, and demonstrated modestly better long-term survival compared with men. Further work is needed to understand factors influencing these trends and to refine sex-specific strategies for optimal outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamacardio.2026.0941","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T15:31:37Z","timestamp":1778081497000},"page":"496","source":"Crossref","is-referenced-by-count":1,"title":["Sex-Based Patterns and Trends in Transcatheter Aortic Valve Implantation"],"prefix":"10.1001","volume":"11","author":[{"given":"Johny","family":"Nicolas","sequence":"first","affiliation":[{"name":"Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York"},{"name":"Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annetine C.","family":"Gelijns","sequence":"additional","affiliation":[{"name":"Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan J.","family":"Moskowitz","sequence":"additional","affiliation":[{"name":"Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin B.","family":"Leon","sequence":"additional","affiliation":[{"name":"Columbia University Irving Medical Center, New York, New York"},{"name":"Clinical Trials Center, Cardiovascular Research Foundation, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Mehran","sequence":"additional","affiliation":[{"name":"Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Chikwe","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Mack","sequence":"additional","affiliation":[{"name":"Baylor Scott & White Health, Dallas, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayra E.","family":"Guerrero","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj R.","family":"Makkar","sequence":"additional","affiliation":[{"name":"Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariell","family":"Jessup","sequence":"additional","affiliation":[{"name":"American Heart Association, Dallas, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick T.","family":"O\u2019Gara","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Egorova","sequence":"additional","affiliation":[{"name":"Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"12","key":"hoi260021r1","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/s41569-021-00570-z","article-title":"Global epidemiology of valvular heart disease.","volume":"18","author":"Coffey","year":"2021","journal-title":"Nat Rev Cardiol"},{"issue":"14","key":"hoi260021r2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.026102","article-title":"Trends in Medicare payments for beneficiaries with aortic stenosis.","volume":"11","author":"van Bakel","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"21","key":"hoi260021r3","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1161\/CIRCULATIONAHA.119.043391","article-title":"Global, regional, and national burden of calcific aortic valve and degenerative mitral valve diseases, 1990-2017.","volume":"141","author":"Yadgir","year":"2020","journal-title":"Circulation"},{"issue":"4","key":"hoi260021r4","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1161\/CIRCRESAHA.116.309306","article-title":"Sex-related discordance between aortic valve calcification and hemodynamic severity of aortic stenosis: is valvular fibrosis the explanation?","volume":"120","author":"Simard","year":"2017","journal-title":"Circ Res"},{"issue":"7","key":"hoi260021r5","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1161\/CIRCULATIONAHA.121.054108","article-title":"Genes that escape X chromosome inactivation modulate sex differences in valve myofibroblasts.","volume":"145","author":"Aguado","year":"2022","journal-title":"Circulation"},{"issue":"1","key":"hoi260021r6","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jcmg.2017.09.019","article-title":"Symptom onset in aortic stenosis: relation to sex differences in left ventricular remodeling.","volume":"12","author":"Singh","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"hoi260021r7","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.018816","article-title":"Excess mortality and undertreatment of women with severe aortic stenosis.","volume":"10","author":"Tribouilloy","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"27","key":"hoi260021r8","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1093\/eurheartj\/ehab242","article-title":"Impact of sex on the management and outcome of aortic stenosis patients.","volume":"42","author":"Bienjonetti-Boudreau","year":"2021","journal-title":"Eur Heart J"},{"issue":"3","key":"hoi260021r9","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.amjcard.2013.10.024","article-title":"Influence of gender on clinical outcomes following transcatheter aortic valve implantation from the UK transcatheter aortic valve implantation registry and the National Institute for Cardiovascular Outcomes Research.","volume":"113","author":"Al-Lamee","year":"2014","journal-title":"Am J Cardiol"},{"issue":"7624","key":"hoi260021r10","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"335","author":"von Elm","year":"2007","journal-title":"BMJ"},{"issue":"21","key":"hoi260021r11","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1016\/j.jacc.2021.02.038","article-title":"Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research.","volume":"77","author":"G\u00e9n\u00e9reux","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"hoi260021r12","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1097\/MLR.0000000000000729","article-title":"Development of a claims-based frailty indicator anchored to a well-established frailty phenotype.","volume":"55","author":"Segal","year":"2017","journal-title":"Med Care"},{"issue":"4","key":"hoi260021r13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0281811","article-title":"Racial and ethnic disparities in diagnosis, management and outcomes of aortic stenosis in the Medicare population.","volume":"18","author":"Ahmed","year":"2023","journal-title":"PLoS One"},{"key":"hoi260021r14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2024.131996","article-title":"Patterns of aortic valve replacement in Europe and adoption by sex.","volume":"406","author":"Bleiziffer","year":"2024","journal-title":"Int J Cardiol"},{"issue":"2","key":"hoi260021r15","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.121.011489","article-title":"Economic considerations in access to transcatheter aortic valve replacement.","volume":"15","author":"Reddy","year":"2022","journal-title":"Circ Cardiovasc Interv"},{"issue":"3","key":"hoi260021r16","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jacc.2013.03.074","article-title":"Transcatheter aortic valve replacement in Europe: adoption trends and factors influencing device utilization.","volume":"62","author":"Mylotte","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"hoi260021r17","doi-asserted-by":"publisher","first-page":"6308","DOI":"10.21037\/jtd-24-406","article-title":"Sex-related disparities in aortic stenosis from disease awareness to treatment: a state-of-the-art review.","volume":"16","author":"Appleby","year":"2024","journal-title":"J Thorac Dis"},{"issue":"4","key":"hoi260021r18","first-page":"362","article-title":"Prevalence, referral patterns, testing, and surgery in aortic valve disease: leaving women and elderly patients behind?","volume":"16","author":"Bach","year":"2007","journal-title":"J Heart Valve Dis"},{"issue":"7","key":"hoi260021r19","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.jcmg.2022.02.007","article-title":"Sex differences in LV remodeling and hemodynamics in aortic stenosis: sex-specific criteria for severe stenosis?","volume":"15","author":"Ito","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"hoi260021r20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcmg.2023.06.006","article-title":"Sex differences in the progression and long-term outcomes of native mild to moderate aortic stenosis.","volume":"17","author":"Hariri","year":"2024","journal-title":"JACC Cardiovasc Imaging"},{"issue":"7","key":"hoi260021r21","doi-asserted-by":"publisher","first-page":"e239","DOI":"10.1161\/CIR.0000000000000907","article-title":"Ten-year differences in women\u2019s awareness related to coronary heart disease: results of the 2019 American Heart Association National Survey: a special report from the American Heart Association.","volume":"143","author":"Cushman","year":"2021","journal-title":"Circulation"},{"issue":"19","key":"hoi260021r22","doi-asserted-by":"publisher","first-page":"5588","DOI":"10.3390\/jcm11195588","article-title":"Epidemiological and clinical features in very old men and women (=80 years) hospitalized with aortic stenosis in Spain, 2016-2019: results from the Spanish Hospital Discharge Database.","volume":"11","author":"Palacios-Fernandez","year":"2022","journal-title":"J Clin Med"},{"issue":"25","key":"hoi260021r23","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1016\/j.jacc.2016.10.041","article-title":"Sex-based differences in outcomes with transcatheter aortic valve therapy: TVT registry from 2011 to 2014.","volume":"68","author":"Chandrasekhar","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"hoi260021r24","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.amjcard.2020.07.052","article-title":"Impact of gender on transcatheter aortic valve implantation outcomes.","volume":"133","author":"Stehli","year":"2020","journal-title":"Am J Cardiol"},{"key":"hoi260021r25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ahj.2024.07.018","article-title":"Sex differences and long-term clinical outcomes after transcatheter aortic valve replacement: a SWEDEHEART study.","volume":"277","author":"Dismorr","year":"2024","journal-title":"Am Heart J"},{"issue":"7","key":"hoi260021r26","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.019429","article-title":"Do women require less permanent pacemaker after transcatheter aortic valve implantation? a meta-analysis and meta-regression.","volume":"10","author":"Ravaux","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"hoi260021r27","doi-asserted-by":"publisher","first-page":"E908","DOI":"10.1002\/ccd.29807","article-title":"Incidence, predictors and clinical impact of permanent pacemaker insertion in women following transcatheter aortic valve implantation: insights from a prospective multinational registry.","volume":"98","author":"Nicolas","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"issue":"3","key":"hoi260021r28","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jacc.2015.05.024","article-title":"Revisiting sex equality with transcatheter aortic valve replacement outcomes: a collaborative, patient-level meta-analysis of 11,310 patients.","volume":"66","author":"O\u2019Connor","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"hoi260021r29","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/ccd.25377","article-title":"Sex differences in postprocedural aortic regurgitation and mid-term mortality after transcatheter aortic valve implantation.","volume":"84","author":"Ferrante","year":"2014","journal-title":"Catheter Cardiovasc Interv"},{"issue":"10513","key":"hoi260021r30","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/S0140-6736(25)01330-3","article-title":"Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950-2023: a demographic analysis for the Global Burden of Disease Study 2023.","volume":"406","author":"GBD 2023 Demographics Collaborators","year":"2025","journal-title":"Lancet"},{"issue":"11","key":"hoi260021r31","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1161\/CIRCULATIONAHA.109.927764","article-title":"Regression of myocardial hypertrophy after aortic valve replacement: faster in women?","volume":"122","author":"Petrov","year":"2010","journal-title":"Circulation"},{"issue":"1","key":"hoi260021r32","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13183","article-title":"Women had favourable reverse left ventricle remodelling after TAVR.","volume":"50","author":"Chen","year":"2020","journal-title":"Eur J Clin Invest"},{"issue":"6","key":"hoi260021r33","doi-asserted-by":"publisher","first-page":"377","DOI":"10.7326\/M15-0121","article-title":"Sex-specific differences at presentation and outcomes among patients undergoing transcatheter aortic valve replacement: a cohort study.","volume":"164","author":"Kodali","year":"2016","journal-title":"Ann Intern Med"},{"issue":"47","key":"hoi260021r34","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1093\/eurheartj\/ehz835","article-title":"Sex differences in heart failure.","volume":"40","author":"Lam","year":"2019","journal-title":"Eur Heart J"},{"issue":"10","key":"hoi260021r35","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1001\/jama.2015.1474","article-title":"Clinical outcomes at 1 year following transcatheter aortic valve replacement.","volume":"313","author":"Holmes","year":"2015","journal-title":"JAMA"},{"issue":"10250","key":"hoi260021r36","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)31561-0","article-title":"Sex and gender: modifiers of health, disease, and medicine.","volume":"396","author":"Mauvais-Jarvis","year":"2020","journal-title":"Lancet"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2848179\/jamacardiology_nicolas_2026_oi_260021_1780929848.22328.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:00:34Z","timestamp":1781103634000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2848179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2026.0941","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,1]]}}}